Mainstreet Equity Corp. (MEQ)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 173.50 |
|---|---|
| 52-week range | 159.93 – 200.84 |
| Return, 1 month / 3 months | +5.0% / −1.7% |
| Return, 1 year / 3 years | −6.1% / +24.3% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 18.1% |
| Worst drawdown (1 year) | -18.8% |
| Average daily value traded | 1.39M CAD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Mainstreet Equity Corp. is a Canadian real estate company that owns and manages residential apartment buildings. It focuses on mid-market rental properties in western Canadian cities, where it acquires buildings and improves them through renovation and active management. Its tenants are ordinary renters seeking affordable apartments, and the company handles leasing, maintenance and property operations itself. Mainstreet Equity Corp. is based in Calgary, Alberta.
Mainstreet Equity Corp. trades under the code MEQ on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Mainstreet Equity Corp. (MEQ) trades on the Toronto Exchange in Canada. It last closed at CAD 173.50 on 19 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 448 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.1% and over the last three months it fell 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.1% | ||
| From 52-week high | -13.1% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -1.7% | ||
| 6-month return | -5.1% | ||
| 12-month return, skipping the last month | -10.6% | ||
| Risk (lower is better) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility (1 year) | 18.1% | ||
| Worst drawdown (1 year) | -18.8% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.39M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 9 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 3 |
Strengths
- Risk (lower is better): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.2% |
|---|---|
| 1 month | +5.0% |
| 3 months | −1.7% |
| 6 months | −5.1% |
| 1 year | −6.1% |
| 3 years | +24.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 167.31 / 173.40 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.17 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | CAD 0.0800 |
| 17 Jul 2026 | CAD 0.0800 |
| 17 Apr 2026 | CAD 0.0800 |
| 16 Jan 2026 | CAD 0.0800 |
| 17 Oct 2025 | CAD 0.0400 |
| 17 Jul 2025 | CAD 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.